Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

NICE Recommends Digital Platforms for Cardiac Rehab

August 19, 2025 Jennifer Chen Health
News Context
At a glance
  • The National Institute ⁢for Health and Care Excellence (NICE) has conditionally recommended six online platforms to broaden access to cardiac rehabilitation for adults living with cardiovascular disease (CVD).
  • The approved platforms include Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, kiactiv, and myHeart.
  • Cardiac rehabilitation⁣ is a well-established therapy demonstrably effective in reducing the risk of subsequent cardiac events and hospital readmissions.However, participation rates in traditional, in-person⁤ programs remain surprisingly low.
Original source: medscape.com

Digital‍ Cardiac Rehab: New Options for a Healthier Heart

Table of Contents

  • Digital‍ Cardiac Rehab: New Options for a Healthier Heart
    • Expanding Access to Life-saving⁤ Rehabilitation
      • Cardiac Rehab: Key Facts
    • Addressing a Critical Gap in Care
    • Evidence Supporting Digital Rehabilitation
    • What to Expect During ‍the Trial and Beyond
    • Further Research Needed

Published August 19, 2025

Expanding Access to Life-saving⁤ Rehabilitation

The National Institute ⁢for Health and Care Excellence (NICE) has conditionally recommended six online platforms to broaden access to cardiac rehabilitation for adults living with cardiovascular disease (CVD). This draft guidance, published on the NICE website, allows for ‍a three-year trial period of these technologies across the national Health Service (NHS). The aim is to‍ empower patients to complete their rehabilitation programs from‍ the comfort of their homes, utilizing smartphones, tablets, or computers.

The approved platforms include Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, kiactiv, and myHeart. These programs offer a comprehensive suite of services, ⁤encompassing tailored exercise programs, vital cardiovascular disease education, dietary guidance, medication management support, and⁤ even psychological assistance. Several platforms also integrate wearable devices to track activity ⁤levels,providing a more personalized experience.

Cardiac Rehab: Key Facts

  • What: NICE conditionally recommends six digital platforms for cardiac‍ rehabilitation.
  • Where: NHS across England.
  • When: 3-year trial period, with‍ recommendations issued August 2025.
  • Why it ⁣matters: Increases ‍access to proven therapy, especially for underserved groups.
  • What’s next: Data collection and review by NICE to determine wider ⁤rollout.

Addressing a Critical Gap in Care

Cardiac rehabilitation⁣ is a well-established therapy demonstrably effective in reducing the risk of subsequent cardiac events and hospital readmissions.However, participation rates in traditional, in-person⁤ programs remain surprisingly low. Data from 2023 reveals that only 41% of eligible patients with acute coronary syndrome and a mere 13% of those with heart failure in England actually participated in these programs.

These digital platforms are specifically designed to bridge this gap, improving access for individuals who have historically faced barriers to participation.‍ This includes women,younger patients,ethnic minorities,and those whose work,travel commitments,or other life⁢ circumstances prevent⁣ them from attending in-person sessions.

Evidence Supporting Digital Rehabilitation

The recommendation isn’t based on theory alone. Clinical data already supports the efficacy of several of these platforms. ⁣ Activate Your Heart has been evaluated in three studies,including ⁣two rigorous ⁢randomized controlled trials (RCTs). KiActiv has been the subject of two studies, one of which was an RCT, and myHeart has ‍been assessed in two trials, including one RCT published in the European Heart Journal – Digital Health.

These ‍studies suggest that digital rehabilitation can lead to improvements in exercise capacity, better cardiovascular risk profiles, ‍and an enhanced overall⁤ quality of life for patients.

Platform Number ⁣of Studies RCTs ‍Included
Activate Your Heart 3 2
KiActiv 2 1
myHeart 2 1

What to Expect During ‍the Trial and Beyond

Over the next three years, a wealth of data will be collected on clinical outcomes, patient engagement across diverse demographics, cost-effectiveness, potential ⁢adverse events, and comparisons with traditional rehabilitation methods. This data will be crucial in informing a final decision by NICE regarding the wider implementation of these technologies within the⁣ NHS.

It’s meaningful to note that NICE emphasizes these platforms should only be used following a thorough clinical assessment by a trained NHS professional.⁣ Digital rehabilitation isn’t suitable for everyone,⁢ and factors like limited digital literacy or lack ‍of access to necessary devices may present barriers for some patients. clinicians will also need to provide additional support to vulnerable groups,including older adults,individuals with disabilities,those experiencing homelessness,and those for whom English is not their first language.

Further Research Needed

While these six platforms show promise, seven others – Beat better, ⁤Datos Health, Get⁤ Ready, Luscii Vitals, Pumping Marvellous Cardiac Rehab‍ Platform, R Plus⁤ Health, and Sword Move – require further⁣ investigation before they can be routinely offered through the NHS. ‍ For now, these will only be available within research settings.

A public consultation on these draft recommendations is open until September 3, 2025, allowing ⁢stakeholders to provide feedback via the NICE website.

– drjenniferchen

This move by NICE⁢ represents a significant step forward in modernizing cardiac care. By ⁣embracing digital solutions, we can overcome ‍longstanding barriers to access and ensure that more⁣ patients benefit from the‍ life-saving effects ⁤of cardiac rehabilitation. The emphasis on rigorous data collection during the trial period is also commendable, ensuring that any wider rollout is based on solid evidence and delivers genuine value to patients and the ‍healthcare system.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

CV risk; cardiovascular risk; CV risk factors; cardiovascular risk factors; cardiovascular risk management; CV risk management, heart, heart failure; heart failure (HF), National Health Service, NHS, UK, UK National Health Service, UK NHS, UK Site Content; United Kingdom Site Content, United Kingdom, United Kingdom National Health Service

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.